Moreover, Sun et al. found the Follistatin-like 3 (FSTL3) regulates the GSK-3β/β-catenin and BMP1/SMAD pathways, enabling RCC proliferation and metastasis (Sun et al., 2021). Here, FSTL3 is linked to renal cell carcinoma.